Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matus Rehak

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Experimental Eye Research|January 17, 2022
Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cellsHeidrun L Deissler, Matus Rehak, Catharina Busch, et al.
Die Ophthalmologie|November 10, 2022
[Ischemia and laser photocoagulation in retinal vein occlusion]Matus Rehak, Marcus Werner Storch, Lars-Olof Hattenbach, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 26, 2022
Retinometer predicts visual outcome in Descemet membrane endothelial keratoplastyCaroline Sophie Wald, Jan Darius Unterlauft, Matus Rehak, et al.
Ophthalmic Research|November 17, 2010
Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusionJiri Rehak, Ladislav Dusek, Oldrich Chrapek, et al.
European Journal of Ophthalmology|November 4, 2022
The epidemiology of adults' eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients' dataAhmad S Alfaar, C Nathanael Suckert, Matus Rehak, et al.
International Journal of Retina and Vitreous|July 11, 2020
Morphology of partial-thickness macular defects: presumed roles of Müller cells and tissue layer interfaces of low mechanical stabilityAndreas Bringmann, Jan Darius Unterlauft, Renate Wiedemann, et al.
Acta Diabetologica|November 22, 2019
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatmentMatus Rehak, Catharina Busch, Jan-Darius Unterlauft, et al.
Acta Ophthalmologica|March 8, 2017
Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusionEric Tilgner, Maiara Dalcegio Favretto, Maria Tuisl, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 4, 2013
Long term visual outcome after arteriolar constriction in patients with branch retinal vein occlusionJiri Rehak, Ladislav Dusek, Martin Sin, et al.
Oncology Research and Treatment|February 26, 2019
A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of CisplatinThomas Golombek, Robert Henker, Matus Rehak, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Experimental Eye Research|January 17, 2022
Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cellsHeidrun L Deissler, Matus Rehak, Catharina Busch, et al.
Die Ophthalmologie|November 10, 2022
[Ischemia and laser photocoagulation in retinal vein occlusion]Matus Rehak, Marcus Werner Storch, Lars-Olof Hattenbach, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 26, 2022
Retinometer predicts visual outcome in Descemet membrane endothelial keratoplastyCaroline Sophie Wald, Jan Darius Unterlauft, Matus Rehak, et al.
Ophthalmic Research|November 17, 2010
Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusionJiri Rehak, Ladislav Dusek, Oldrich Chrapek, et al.
European Journal of Ophthalmology|November 4, 2022
The epidemiology of adults' eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients' dataAhmad S Alfaar, C Nathanael Suckert, Matus Rehak, et al.
International Journal of Retina and Vitreous|July 11, 2020
Morphology of partial-thickness macular defects: presumed roles of Müller cells and tissue layer interfaces of low mechanical stabilityAndreas Bringmann, Jan Darius Unterlauft, Renate Wiedemann, et al.
Acta Diabetologica|November 22, 2019
Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatmentMatus Rehak, Catharina Busch, Jan-Darius Unterlauft, et al.
Acta Ophthalmologica|March 8, 2017
Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusionEric Tilgner, Maiara Dalcegio Favretto, Maria Tuisl, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 4, 2013
Long term visual outcome after arteriolar constriction in patients with branch retinal vein occlusionJiri Rehak, Ladislav Dusek, Martin Sin, et al.
Oncology Research and Treatment|February 26, 2019
A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of CisplatinThomas Golombek, Robert Henker, Matus Rehak, et al.
Pageof 10